B
16.59
-0.83 (-4.76%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | Beta Bionics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
-0.6
| 分析师共识 | NA |
| 内部交易活动 | -2.5 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.61 |
|
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Growth |
| 内部持股比例 | 6.51% |
| 机构持股比例 | 98.41% |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| FEIDER STEPHEN | - | 19.42 | -6,675 | -129,595 |
| HOPMAN MARK | - | 19.42 | -5,327 | -103,424 |
| MENSINGER MIKE | - | 19.42 | -4,375 | -84,941 |
| RUSSELL STEVEN JON | - | 19.42 | -4,221 | -81,951 |
| SAINT SEAN | - | 19.67 | -22,508 | -439,842 |
| 累积净数量 | -43,106 | |||
| 累积净值 ($) | -839,752 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 19.50 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| SAINT SEAN | 职员 | 03 Sep 2026 | 自动卖出 (-) | 5,641 | 19.92 | 112,369 |
| SAINT SEAN | 职员 | 02 Sep 2026 | 卖 (-) | 16,867 | 19.42 | 327,473 |
| FEIDER STEPHEN | 职员 | 02 Sep 2026 | 卖 (-) | 6,675 | 19.42 | 129,595 |
| RUSSELL STEVEN JON | 职员 | 02 Sep 2026 | 卖 (-) | 4,221 | 19.42 | 81,951 |
| HOPMAN MARK | 职员 | 02 Sep 2026 | 卖 (-) | 5,327 | 19.42 | 103,424 |
| MENSINGER MIKE | 职员 | 02 Sep 2026 | 卖 (-) | 4,375 | 19.42 | 84,941 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合